Neuropathic pain in spinal cord injury: topical analgesics as a possible treatment

[1]  R. V. van Eijk,et al.  Usefulness of a Double-Blind Placebo-Controlled Response Test to Demonstrate Rapid Onset Analgesia with Phenytoin 10% Cream in Polyneuropathy , 2020, Journal of pain research.

[2]  D. J. Kopsky,et al.  Ethical justification of single-blind and double-blind placebo-controlled response tests in neuropathic pain and N-of-1 treatment paradigm in clinical settings , 2019, Journal of pain research.

[3]  D. J. Kopsky,et al.  Single-Blind Placebo-Controlled Response Test with Phenytoin 10% Cream in Neuropathic Pain Patients , 2018, Pharmaceuticals.

[4]  R. Baron,et al.  Stratification of neuropathic pain patients: the road to mechanism-based therapy? , 2018, Current opinion in anaesthesiology.

[5]  L. Nikolajsen,et al.  How central is central poststroke pain? The role of afferent input in poststroke neuropathic pain: a prospective, open-label pilot study , 2018, Pain.

[6]  O. Lennon,et al.  Quality of life after spinal cord injury: The impact of pain , 2018, European journal of pain.

[7]  R. Treede,et al.  Pathophysiological mechanisms of neuropathic pain: comparison of sensory phenotypes in patients and human surrogate pain models , 2018, Pain.

[8]  J. Kramer,et al.  Placebo response in neuropathic pain after spinal cord injury: a meta-analysis of individual participant data , 2018, Journal of pain research.

[9]  G. Carlson,et al.  Neuropathic pain and SCI: Identification and treatment strategies in the 21st century , 2018, Journal of the Neurological Sciences.

[10]  N. Finnerup.  Neuropathic pain and spasticity: intricate consequences of spinal cord injury , 2017, Spinal Cord.

[11]  J. Benito-Penalva,et al.  Depression in Individuals With Traumatic and Nontraumatic Spinal Cord Injury Living in the Community. , 2017, Archives of physical medicine and rehabilitation.

[12]  G. Cruccu,et al.  Topical Treatment of Peripheral Neuropathic Pain: Applying the Evidence. , 2017, Journal of pain and symptom management.

[13]  Robert Teasell,et al.  Systematic Review of Pharmacologic Treatments of Pain After Spinal Cord Injury: An Update. , 2016, Archives of physical medicine and rehabilitation.

[14]  D. Wolfe,et al.  The CanPain SCI Clinical Practice Guidelines for Rehabilitation Management of Neuropathic Pain after Spinal Cord: Recommendations for treatment , 2016, Spinal Cord.

[15]  F. Ambrosio,et al.  Lidocaine 5% Medicated Plaster for Spinal Neuropathic Pain , 2016, Journal of pain & palliative care pharmacotherapy.

[16]  J. V. van Middendorp,et al.  Top ten research priorities for spinal cord injury: the methodology and results of a British priority setting partnership , 2015, Spinal Cord.

[17]  Raveendhara R. Bannuru,et al.  Effectiveness and Implications of Alternative Placebo Treatments , 2015, Annals of Internal Medicine.

[18]  Michelle Trbovich,et al.  Capsaicin 8% Patch for Central and Peripheral Neuropathic Pain of Persons with Incomplete Spinal Cord Injury: Two Case Reports , 2015, American journal of physical medicine & rehabilitation.

[19]  D. J. Kopsky,et al.  Walking with Neuropathic Pain: Paradoxical Shift from Burden to Support? , 2015, Case reports in medicine.

[20]  T. Wager,et al.  Conditioned placebo analgesia persists when subjects know they are receiving a placebo. , 2015, The journal of pain : official journal of the American Pain Society.

[21]  A. Kessels,et al.  Pain prevalence and its determinants after spinal cord injury: A systematic review , 2015, European journal of pain.

[22]  E. von Elm,et al.  Non-pharmacological interventions for chronic pain in people with spinal cord injury. , 2014, The Cochrane database of systematic reviews.

[23]  R. Baron,et al.  Phenotyping neuropathic pain patients: implications for individual therapy and clinical trials , 2014, Current opinion in supportive and palliative care.

[24]  D. J. Kopsky,et al.  Intractable neuropathic pain in spinal intramedullary cavernoma treated successfully with a novel combination cream. , 2012, Pain medicine.

[25]  G. Wasner,et al.  Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment , 2010, The Lancet Neurology.

[26]  D. Wolfe,et al.  A systematic review of pharmacologic treatments of pain after spinal cord injury. , 2010, Archives of physical medicine and rehabilitation.

[27]  W. Willis,et al.  Peripheral and central sensitization in remote spinal cord regions contribute to central neuropathic pain after spinal cord injury , 2009, PAIN®.

[28]  P. Siddall.  Management of neuropathic pain following spinal cord injury: now and in the future , 2009, Spinal Cord.

[29]  G. Hans,et al.  Treatment of an acute severe central neuropathic pain syndrome by topical application of lidocaine 5% patch: a case report , 2008, Spinal Cord.

[30]  G. Wasner,et al.  A role for peripheral afferents in the pathophysiology and treatment of at-level neuropathic pain in spinal cord injury? A case report , 2007, Pain.

[31]  S. Rutkowski,et al.  A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury , 2003, Pain.

[32]  A. Rice,et al.  Mechanisms of neuropathic pain. , 2001, British journal of anaesthesia.

[33]  J. Broton,et al.  Perceived difficulty in dealing with consequences of spinal cord injury. , 1999, Archives of physical medicine and rehabilitation.

[34]  B. Strickland,et al.  Recommendations for treatment. , 1990 .